Lista de obras -

Acute hepatic failure in the course of alcohol-paracetamol syndrome--case report.

artículo científico publicado en 2003

Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.

artículo científico publicado en 2015

Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis

artículo científico publicado en 2021

Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.

artículo científico publicado en 2012

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

artículo científico publicado en 2020

Anthrax as a pathogen for a biological weapon

artículo científico publicado en 2003

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.

artículo científico publicado en 2013

Budd-Chiari syndrome--from diagnosis to treatment--case reports

artículo científico publicado en 2008

Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?

artículo científico publicado en 2014

Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study

artículo científico publicado en 2020

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study.

artículo científico publicado en 2015

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

artículo científico publicado en 2017

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study

artículo científico publicado en 2021

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4.

artículo científico publicado en 2018

Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively

artículo científico publicado en 2012

Impact of selected predictive factors on sustained virologic response in HCV genotype 4 infected patients treated with pegylated interferon alpha and ribavirin

artículo científico publicado en 2017

Interferon-induced thyroiditis during treatment of chronic hepatitis C.

artículo científico publicado en 2012

Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin

artículo científico publicado en 2017

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha

artículo científico publicado en 2008

Preparation of HCV infected patients to the triple therapy with first generation protease inhibitors

artículo científico

Prophylaxis of vertical HBV infection

artículo científico publicado en 2016

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

artículo científico publicado en 2020

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

artículo científico publicado en 2022

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

artículo científico publicado en 2020

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

artículo científico publicado en 2020

Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors

artículo científico publicado en 2015

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

artículo científico publicado en 2015

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.

artículo científico publicado en 2015

The increased of alanine aminotransferase in rotavirus diarrhea

artículo científico publicado en 2008

Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis

artículo científico publicado en 2014

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

artículo científico publicado en 2021

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

artículo científico publicado en 2021

Virological response to treatment with peginterferon alfa-2a in adolescents with chronic hepatitis B.

artículo científico publicado en 2012

[Combined vaccine against hepatitis A and B]

artículo científico publicado en 2004

[Forecasting of efficacy of chronic hepatitis B therapy]

artículo científico publicado en 2012

[Leptospirosis--disease with many faces]

[Prevalence of borreliosis among forestry workers in Kujawsko-Pomorskie voivodeship]

scientific article published on 01 January 2007

[Q fever--case report].

artículo científico publicado en 2006

[Tuberculosis among HIV infected patients]

artículo científico publicado en 2008

Lista de obras de

Acute hepatic failure in the course of alcohol-paracetamol syndrome--case report.

Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.

Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis

Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

Anthrax as a pathogen for a biological weapon

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.

Budd-Chiari syndrome--from diagnosis to treatment--case reports

Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?

Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study.

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4.

Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively

Impact of selected predictive factors on sustained virologic response in HCV genotype 4 infected patients treated with pegylated interferon alpha and ribavirin

Interferon-induced thyroiditis during treatment of chronic hepatitis C.

Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha

Preparation of HCV infected patients to the triple therapy with first generation protease inhibitors

Prophylaxis of vertical HBV infection

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.

The increased of alanine aminotransferase in rotavirus diarrhea

Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

Virological response to treatment with peginterferon alfa-2a in adolescents with chronic hepatitis B.

[Combined vaccine against hepatitis A and B]

[Forecasting of efficacy of chronic hepatitis B therapy]

[Leptospirosis--disease with many faces]

[Prevalence of borreliosis among forestry workers in Kujawsko-Pomorskie voivodeship]

[Q fever--case report].

[Tuberculosis among HIV infected patients]